Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Cancer Research
|
July 3, 2024
E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer
Geonhui Lee, Claudia Wong, Anna Cho, et al.
Science (New York, N.Y.)
|
November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D Leone, Liang Zhao, Judson M Englert, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation
|
April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Journal of Neurology
|
April 28, 2026
X-linked Emery-Dreifuss muscular dystrophy: a multicenter, Italian, cohort study
A Elkoush, R Giossi, G Gadaleta, et al.
Cancer Immunology Research
|
May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers
Monali Praharaj, Fan Shen, Alex J Lee, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
The Journal of Clinical Investigation
|
August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
W Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Cancer Research
|
July 3, 2024
E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer
Geonhui Lee, Claudia Wong, Anna Cho, et al.
Science (New York, N.Y.)
|
November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D Leone, Liang Zhao, Judson M Englert, et al.
Science Advances
|
November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation
|
April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Journal of Neurology
|
April 28, 2026
X-linked Emery-Dreifuss muscular dystrophy: a multicenter, Italian, cohort study
A Elkoush, R Giossi, G Gadaleta, et al.
Cancer Immunology Research
|
May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers
Monali Praharaj, Fan Shen, Alex J Lee, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
The Journal of Clinical Investigation
|
August 9, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
W Brian Dalton, Eric Helmenstine, Noel Walsh, et al.
Page
of 9